Our efforts have revealed that S100A8/A9 induces the metastatic progression of breast cancer cells upon binding with an S100A8/A9 receptor, i.e., melanoma cell adhesion molecule (MCAM) on cancer cells (3). Here, IGKV1D-22 is linked to cancer.